Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. BUFENCON INJECTION [SIN07795P]

BUFENCON INJECTION [SIN07795P]

Active ingredients: BUFENCON INJECTION

Last updated 26 October 2025

Product Info

BUFENCON INJECTION

[SIN07795P]

Product information

Active Ingredient and Strength

BETAMETHASONE DIPROPIONATE EQV BETAMETHASONE - 5 MG/ML
BETAMETHASONE PHOSPHATE DISODIUM EQV BETAMETHASONE - 2 MG/ML

Dosage Form

INJECTION

Manufacturer and Country

YUNG SHIN PHARMACEUTICAL IND CO LTD - TAIWAN

Registration Number

SIN07795P

Licence Holder

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

H02AB01

INDICATIONS:
Musculoskeletal and soft tissue inflammatory conditions, allergic dermatologic conditions, and collagen diseases.

DOSAGE AND ADMINISTRATION:
Intramuscular Injection: 1.0mL repeated according to the response of the condition.

  1. Effective control of symptoms with 1.0–2.0 mL is obtained in bronchial asthma, hay fever, allergic bronchitis and allergic rhinitis. Onset of relief has occurred within a few hours of intramuscular injection.

  2. In the treatment of acute or chronic bursitis, excellent results are obtained with intramuscular injection of 1.0–2.0 mL, repeated as necessary.

Local administration:

  1. Intra-articular Injection:
    Large joints (knee, hip, shoulder): 1.0–2.0 mL
    Medium joints (below the wrist, ankle): 0.5–1.0 mL
    Small joints (foot, hand, chest): 0.25–0.5 mL

  2. Intradermal Injection:
    For dermatologic conditions, 0.2 mL/cm2 with a tuberculin syringe and a small 26-gauge needle is recommended. The total amount of Bufencon Injection injected at all sites each week should not exceed 1.0 mL.

  3. Intralesional Injection:
    A tuberculin syringe with a small 25-gauge needle is suitable for most injections into the foot. Recommended doses at intervals of approximately one week: bursitis under heloma durum or molle, 0.25–0.5 mL; bursitis under calcaneal spur, 0.5 mL; bursitis over hallux rigidus, 0.5 mL; bursitis over digiti quinti varus, 0.5 mL; synovial cyst, 0.25–0.5 mL; Morton's neuralgia (metatarsalgia), 0.25–0.5 mL; tenosynovitis, 0.5 mL; periostitis of cuboid, 0.5 mL; acute gouty arthritis, 0.5–1.0 mL.
    To be administered only by a physician.

CONTRAINDICATIONS:
As with other corticosteroid preparations, Bufencon Injection is contra-indicated in systemic infections.
Corticosteroids should not be injected into unstable joints, infected areas, or intervertebral spaces.